Alimera Sciences Inc (ALIM) Return on Investment ROI from the second quarter of 2024 to second quarter of 2023 and for the year 2024, average high and low, overall ranking from Jun 30 2024 to Jun 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Alimera Sciences Inc  (NASDAQ: ALIM)


Alimera Sciences Inc's ROI from its second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Alimera Sciences Inc's ROI in the second quarter of 2024?
Alimera Sciences Inc recorded a cumulative net loss of $-15 million during 12 months ending in the second quarter of 2024, resulting in a negative return on investment (ROI) of -12.78%.

Within the Healthcare sector 275 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2024 from 2730 to 3176.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Investment Change TTM 234.07 % 817.7 % 536.29 % 133.71 % -7.99 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 114 116 116 113 110
Return On Investment (TTM) -12.78 % -18.79 % -22.07 % -32.69 % -69.81 %
ALIM's Overall Ranking # 3176 # 2730 # 2343 # 1193 # 4283
Seq. Investment Change TTM 0.93 % 24.89 % 48.14 % 78.9 % 177.26 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -15 -21 -20 -20 -24

ALIM Company Profile >> Back to ALIM Roi Comparisons >> See Annual ALIM Return On Investment



Return On Investment ALIM's Ranking
Within: No.
Industry # 90
Sector # 276
Overall # 3176

Return On Investment Statistics
High Average Low
152.44 %
-56.78 %
-485.58 %
(Jun 30 2019)   (Mar 31 2014)



  News about Alimera Sciences Inc Return on Investment ROI

Alimera Sciences Appoints Todd Wood as President U.S. Amidst Financial Turmoil, Gearing Up for Strides in Retinal Health

December 12, 2023



Alimera Sciences, a prominent global pharmaceutical company focused on retinal health, recently announced the appointment of Todd Wood as the President of U.S. operations. This strategic move comes as the company strives to deliver its mission of being invaluable to patients, physicians, and partners in maintaining better vision over the long term.
Wood s extensive expertise and leadership experience in the pharmaceutical industry make him well-equipped to steer Alimera s U.S. operations towards achieving its strategic goals. With his immediate inclusion as President, Alimera aims to leverage Wood s proficiency in business strategy, commercial execution, and operational excellence.





Financial Statements
Alimera Sciences Inc's II. Quarter Investments $ 114 Millions ALIM's Balance sheet
Alimera Sciences Inc's II. Quarter Income $ -3 Millions Quarterly ALIM's Income Statement
ALIM's Income by Division See ALIM's Income by Division


ALIM Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions 116 -2 46 34 38
Y / Y Investment Growth - - 33.4 % -9.79 % -13.01 %
Net Income in Millions -20 -18 -4 -5 -10
Y / Y Net Income Growth - - - - -
Annual Return On Investment -17.28 % - -9.52 % -15.51 % -27.36 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ALIM's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ALIM's Competitors
Subscribers only: Roi for Alimera Sciences Inc's Suppliers
Subscribers only: Return On Investment for ALIM's Customers

Other Ratios
ALIM's Roa ALIM's Inventory Turnover Ratio ALIM's Growth Rates ALIM's Dividend Statistics
ALIM's Profitability Ratios ALIM's Asset Turnover Ratio ALIM's Dividend Growth
ALIM's Roe ALIM's Valuation Ratios ALIM's Financial Strength Ratios ALIM's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2024, within Healthcare Sector ROI

Date modified: 2026-09-08T15:11:18+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.